Showing 97–112 of 398 results
-
16%
BIOFIRE-RESPIRATORY PANEL 2.1
The BioFire Blood Culture Identification (BCID) panel is a rapid molecular test used to identify the causative agent of bloodstream infections (BSIs) in patients with positive blood cultures. It detects multiple pathogens and antimicrobial resistance genes in a single test, aiding in the timely management of sepsis and other BSI-related conditions. The panel is typically used on the BioFire FilmArray system.
Here’s a more detailed breakdown:
Purpose:
Rapid Identification:
The BCID panel helps quickly identify the specific bacteria, fungi, or other microorganisms responsible for a bloodstream infection.
Antimicrobial Resistance Detection:
It also detects genetic markers associated with antimicrobial resistance, allowing for better-targeted antibiotic therapy.
Improved Sepsis Management:
Rapid identification and resistance detection can lead to quicker adjustment of broad-spectrum antibiotics to more specific regimens, potentially reducing antibiotic use and hospital stay.
How it Works:
Multiplex PCR: The panel uses a multiplex PCR (polymerase chain reaction) technology to detect multiple targets simultaneously.
FilmArray System: It is designed for use with the BioFire FilmArray system.
Sample Preparation: A positive blood culture sample is processed, and the DNA is amplified and analyzed within the FilmArray system.
Benefits:
Faster Results:
The test provides results in about an hour from a positive blood culture, compared to days for traditional culture-based methods.₹18,000.00Original price was: ₹18,000.00.₹15,000.00Current price is: ₹15,000.00. -
4%
₹1,050.00Original price was: ₹1,050.00.₹1,000.00Current price is: ₹1,000.00. -
6%
₹800.00Original price was: ₹800.00.₹750.00Current price is: ₹750.00. -
2%
BONE PROFILE – BASIC
A bone profile blood test assesses bone health by measuring levels of key minerals, proteins, and enzymes in the blood, providing insights into bone turnover, mineral balance, and overall skeletal health.Here’s a more detailed explanation:What a Bone Profile Measures:-
-
Calcium:Essential for bone health, nerve function, and muscle contraction.
-
Phosphate:Works with calcium to maintain bone health and is crucial for energy production and cell function.
-
-
Alkaline Phosphatase (ALP):An enzyme produced by osteoblasts during bone formation; elevated levels can indicate increased bone turnover or bone growth.
-
Albumin:A protein created in the liver, low levels are associated with lower bone density.
-
Other markers:Depending on the specific test, a bone profile may also include markers like osteocalcin (a protein produced by osteoblasts during bone formation).
Why Bone Profile Tests are Important:-
Diagnosis:Bone profile tests can help diagnose and monitor conditions like osteoporosis, Paget’s disease of the bone, and other bone disorders.
-
Monitoring Bone Health:They can track bone turnover and mineral balance, helping healthcare professionals assess the overall health of the skeleton.
-
Evaluating Metabolic Processes:The test helps determine how well the body’s metabolic processes are affecting the skeleton.
-
Assessing Bone Density:A bone density scan (DEXA scan) is often used alongside a bone profile to assess bone strength and density.
When a Bone Profile Test Might Be Recommended:-
Osteoporosis Risk Factors:Individuals with a family history of osteoporosis, those who have experienced fractures, or those who are at risk due to age or other factors may be recommended for a bone profile.
-
Suspected Bone Disorders:If someone has symptoms or signs of bone problems, such as pain, fractures, or changes in bone density, a bone profile might be ordered.
-
Monitoring Treatment:Bone profile tests can be used to monitor the effectiveness of treatments for bone disorders.
-
Other Conditions:Bone profile tests can also be used to assess conditions that affect bone health, such as kidney problems, liver disease, or hormone imbalances.
₹2,250.00Original price was: ₹2,250.00.₹2,200.00Current price is: ₹2,200.00. -
-
4%
C-PEPTIDE FASTING, SERUM
C-Peptide is useful in distinguishing Insulinomas from exogenous insulin administration. It’s concentrations are severely decreased or absent in Type I Diabetes mellitus. C-Peptide is also useful in monitoring patients who have received islet cell or pancreatic transplants.
A C-peptide fasting serum test measures the amount of insulin your body produces. It’s a blood test that involves fasting overnight.Purpose-
- To diagnose and monitor diabetes
- To determine the cause of low blood sugar
- To monitor treatment for tumors in the pancreas
- To evaluate pancreatic function
How it’s performed- After fasting for 8 to 12 hours, a blood sample is taken in a red-top or gel-barrier tube
- The serum is separated from the cells and transferred to a transport tube
- The sample is refrigerated and transported
What it shows- High levels of C-peptide indicate type 2 diabetes
- Low levels of C-peptide indicate type 1 diabetes
- C-peptide levels can help distinguish between endogenous insulin (produced by the pancreas) and exogenous insulin (administered externally)
Other uses- C-peptide levels can help guide treatment decisions for diabetes or other insulin-related conditions
- C-peptide levels can help monitor the health and function of the pancreas
₹1,050.00Original price was: ₹1,050.00.₹1,000.00Current price is: ₹1,000.00. -
-
4%
C-PEPTIDE POST PRANDIAL, SERUM
C-Peptide is useful in distinguishing Insulinomas from exogenous insulin administration. It’s concentrations are severely decreased or absent in Type I Diabetes mellitus. C-Peptide is also useful in monitoring patients who have received islet cell or pancreatic transplants.
A postprandial C-peptide serum test measures the amount of C-peptide in your blood after eating. C-peptide is a byproduct of insulin production, and measuring it can help determine how well your pancreas is responding to food.What it’s used for-
- Diagnosing and managing diabetes
- Distinguishing between type 1 and type 2 diabetes
- Tailoring treatment plans
- Helping to find the cause of hypoglycemia (low blood sugar)
How it works- The pancreas releases equal amounts of C-peptide and insulin into the bloodstream
- C-peptide stays in the blood longer than insulin, making it easier to measure
- A C-peptide test can’t diagnose diabetes, but it can indicate if your body can produce insulin
What to expect- You may need to fast overnight before the test
- The test is performed using a blood sample
- The sample is collected in a red-top tube or gel-barrier tube
- The sample is refrigerated during transport and storage
₹1,050.00Original price was: ₹1,050.00.₹1,000.00Current price is: ₹1,000.00. -
-
37%
₹1,200.00Original price was: ₹1,200.00.₹750.00Current price is: ₹750.00. - 4%
-
1%
CARDIAC PROFILE – BASIC
Heart failure (HF) has been recognized as a common complication of diabetes, with a prevalence of up to 22% in individuals with diabetes and increasing incidence rates. Detection of people at high risk for HF (stage A) or those with stage B HF (without symptoms but with either structural/ functional cardiac abnormalities or elevated biomarkers natriuretic peptides or troponin) would permit earlier implementation of effective strategies to prevent or delay the progression to advanced HF in individuals with diabetes
₹3,050.00Original price was: ₹3,050.00.₹3,000.00Current price is: ₹3,000.00. -
4%
₹1,250.00Original price was: ₹1,250.00.₹1,200.00Current price is: ₹1,200.00. -
3%
CARDIAC RISK MARKERS – ADVANCED
Indians are at very high risk of developing Atherosclerotic Cardiovascular disease (ASCVD), they usually get the disease at an early age, have a more severe form of the disease and have poorer outcome as compared to the western populations. This is due to high prevalence of Atherogenic dyslipidemia, central abdominal adiposity & increased transfats in our diet. Among the various risk factors for ASCVD such as dyslipidemia, Diabetes mellitus, sedentary lifestyle, Hypertension, smoking, genetic predisposition etc., dyslipidemia has the highest population attributable risk for MI. Hence monitoring lipid profile regularly for effective management of dyslipidemia remains one of the most important healthcare targets for prevention of ASCVD. This monitoring should start as early as 20 years of age. Lipid association of India (LAI 2020) has categorized individuals into Low risk, Moderate risk, High risk, Very high risk & Extreme risk on the basis of their LDL-C, Non-HDL-C & ApoB blood levels. Use of lipid lowering drugs particularly statins has reduced ASCVD morbidity and mortality; however significant residual risk for the events remains. Additional testing for inflammatory (HsCRP), non-lipid (Homocysteine) and other lipid biomarkers (Apo A, Apo B & Lp(a) ) may be considered for risk refinement. Presence of one or more secondary risk factor should prompt the clinician to consider drug therapy for patient whose atherogenic cholesterol level is higher than goal level.
₹1,550.00Original price was: ₹1,550.00.₹1,500.00Current price is: ₹1,500.00. -
9%
₹550.00Original price was: ₹550.00.₹500.00Current price is: ₹500.00. -
9%
₹550.00Original price was: ₹550.00.₹500.00Current price is: ₹500.00. -
9%
₹550.00Original price was: ₹550.00.₹500.00Current price is: ₹500.00. -
15%
CARDIOMETABOLIC SYNDROME PANEL
Cardiometabolic syndrome represent a cluster of interrelated risk factors, primarily hypertension, elevated fasting blood sugar, dyslipidemia, abdominal obesity and elevated triglycerides. Cardiometabolic health has emerged as a concern due to increasing trend in development of Obesity and Metabolic syndrome which are independent risk factors for Cardiovascular Diseases and other complications. The two most important risk factors defined by National Heart, Lung and Blood Institute are Central obesity and Insulin resistance. Other risk factors include age, family history, lack of exercise and Polycystic Ovarian Syndrome. Metabolic syndrome increases the risk of development of Type 2 Diabetes Mellitus, Cardiovascular complications like Atherosclerosis, Peripheral Vascular Disease, Heart attack, Stroke as well as Non Alcoholic Fatty Liver Disease (NAFLD). The syndrome is typically asymptomatic thus it is recommended to measure additional biomarkers associated with insulin resistance.
₹3,200.00Original price was: ₹3,200.00.₹2,700.00Current price is: ₹2,700.00. -
6%
₹3,200.00Original price was: ₹3,200.00.₹3,000.00Current price is: ₹3,000.00.
